Filter Results:
(2,542)
Show Results For
- All HBS Web
(5,359)
- People (16)
- News (1,973)
- Research (2,542)
- Events (3)
- Multimedia (222)
- Faculty Publications (1,903)
Show Results For
- All HBS Web
(5,359)
- People (16)
- News (1,973)
- Research (2,542)
- Events (3)
- Multimedia (222)
- Faculty Publications (1,903)
Sort by
- 31 May 2016
- First Look
May 31, 2016
June 2016 Medical Care Vaccination Rates Are Associated with Functional Proximity but Not Base Proximity of Vaccination Clinics By: Beshears, John, James J. Choi, David Laibson, Brigitte C. Madrian, and Gwendolyn I. Reynolds... View Details
Keywords: Sean Silverthorne
- 15 Sep 2009
- First Look
First Look: September 15
the director and the quality of the prior LBO experience. This effect is robust to the most likely alternative explanations and supports the idea that directors and social networks play an influential role in change-of-control... View Details
Keywords: Martha Lagace
- April 2012
- Case
Bella Healthcare India
By: Dorothy Leonard and Sunru Yong
Bella Healthcare India was originally established in Bangalore as a low-cost manufacturing facility for a U.S.-based cardiology equipment developer. Under country manager Joseph Cherian it evolved considerably, developing its own research and development capabilities.... View Details
Keywords: India; Productivity; Organizational Development; International Business; R＆D; Cross-cultural Relations; Medical Equipment ＆ Devices; Joint Ventures; Medical Specialties; Research and Development; Product Development; Organizational Change and Adaptation; Strategy; Decision Choices and Conditions; Health Care and Treatment; Product Launch; Failure; Cross-Cultural and Cross-Border Issues; Medical Devices and Supplies Industry; Bangalore
Leonard, Dorothy, and Sunru Yong. "Bella Healthcare India." Harvard Business School Brief Case 124-440, April 2012.
- 10 Jun 2014
- First Look
First Look: June 10
such as talent and capital, away from wealth creation and toward wealth distribution. It distorts thinking. Restoring the balance of power is critical to the competitiveness and the health of the rest of the economy. Limits on the size... View Details
Keywords: Sean Silverthorne
- 03 Nov 2009
- First Look
First Look: Nov. 3
variety of quality improvement strategies. Highlights quality improvement collaborative—organized programs popularized by the Institute for Healthcare Improvement in which teams from multiple institutions... View Details
Keywords: Martha Lagace
- 13 May 2014
- First Look
First Look: May 13
Harvard Business School Case 714-471 Martini Klinik: Prostate Cancer Care Since its establishment in 2005, Hamburg's Martini Klinik had single mindedly focused on prostate cancer care with a commitment to... View Details
Keywords: Sean Silverthorne
- 14 Dec 2011
- Research & Ideas
The New Measures for Improving Nonprofit Performance
speak the same language for the most part. In the social sector we don't have nearly that degree of agreement over what constitutes useful, common metrics, even in subsectors like health care, education, and the environment. At the moment... View Details
Keywords: by Julia Hanna
- 21 Feb 2012
- First Look
First Look: Feb. 21
the low achievement levels of these four countries and the incredible amount of heterogeneity within each of them. Salience in Quality Disclosure: Evidence from the U.S. News College Rankings Authors:Michael Luca and Jonathan Smith... View Details
Keywords: Sean Silverthorne
- 11 Oct 2004
- Research & Ideas
Four Ways to Create Lasting Change
Clinics in Minnesota. That effort produced enduring behavioral and cultural changes regarding an issue (medical errors) that has proven very difficult to address for many health care institutions. Moving... View Details
Keywords: by Martha Lagace
- 2024
- Working Paper
Prozac—Controversial Blockbuster: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes the development of Prozac, a blockbuster drug that transformed
the treatment of depression – and became a cultural phenomenon in the United States. Specifically, we
chronicle the: 1) prior treatments for depression and the research that... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Prozac—Controversial Blockbuster: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-135, July 2020. (Revised May 2024.)
- 2025
- Working Paper
Gastrointestinal Endoscopy--Without Cutting In: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how endoscopy transformed the diagnosis of ulcers, cancerous polyps, and other alimentary canal diseases and enabled “minimally invasive” surgeries to treat such diseases. Specifically, we chronicle how: 1) flexible glass fiber endoscopes... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Gastrointestinal Endoscopy--Without Cutting In: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-005, July 2019. (Revised January 2025.)
- 2014
- Working Paper
Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms
By: Prithwiraj Choudhury and Tarun Khanna
Since the 1990s, several Western firms have filed patents based on medicinal herbs from emerging markets, evoking protests from local stakeholders against 'bio-piracy'. We explore conditions under which firms and local stakeholders share rents from such patents. Our... View Details
Keywords: Rents From New Technology; Local Stakeholders; Herbal Patents; QCA; Fuzzy Set Analysis; Qualitative Case Studies; Plant-Based Agribusiness; Patents; Emerging Markets; Health Care and Treatment; Business and Stakeholder Relations; Cross-Cultural and Cross-Border Issues; Agriculture and Agribusiness Industry; Pharmaceutical Industry
Choudhury, Prithwiraj, and Tarun Khanna. "Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms." Harvard Business School Working Paper, No. 14-081, February 2014.
- August 2009 (Revised April 2012)
- Case
Genzyme's CSR Dilemma: How to Play its HAND
By: Christopher A. Bartlett, Tarun Khanna and Prithwiraj Choudhury
Genzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases (e.g., malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should... View Details
Keywords: Global Strategy; Health Care and Treatment; Intellectual Property; Corporate Social Responsibility and Impact; Partners and Partnerships; Research and Development; Biotechnology Industry
Bartlett, Christopher A., Tarun Khanna, and Prithwiraj Choudhury. "Genzyme's CSR Dilemma: How to Play its HAND." Harvard Business School Case 910-407, August 2009. (Revised April 2012.)
- 15 Oct 2013
- First Look
First Look: October 15
governments holding a non-permanent seat on the United Nations Security Council or an Executive Directorship at the World Bank-are no more likely, on average, to get a negative quality rating than other projects. When aid is given to... View Details
Keywords: Sean Silverthorne
- 06 Dec 2016
- First Look
December 6, 2016
By: Kaplan, Robert S., Derek A. Haas, and Jonathan Warsh Abstract—The prevailing fee-for-service payment model has led health care administrators and physician practices to impose severe constraints on the... View Details
Keywords: Sean Silverthorne
- 09 Dec 2008
- First Look
First Look: December 9, 2008
roles that various constituencies played in the development process. Purchase the case: http://harvardbusinessonline.hbsp.harvard.edu/ b01/en/common/item_detail.jhtml?id=207027 Note on Accountability in the U.S. Health View Details
Keywords: Martha Lagace
- 24 Sep 2013
- First Look
First Look: September 24
invest in platform quality in open-source and proprietary two-sided platforms. Open platforms have open access, and developers invest to improve the platform. Proprietary platforms have closed access, and investment is done by the... View Details
Keywords: Sean Silverthorne
- 12 Mar 2014
- Research & Ideas
Entrepreneurship and Multinationals Drive Globalization
War I, the management of political risk became a central concern for firms operating internationally. These risks were on many levels, from expropriation to exchange controls and other economic policies. The issue is explored in multiple chapters, but the chapter on... View Details
- 07 Mar 2013
- Research & Ideas
Video: Harvard Business School at the Kumbh Mela
interviews with Hindu religious leaders as to why this pilgrimage matters, along with SPH's findings about all things health related, from the bacteria count in the Ganges to the quality of medical care.... View Details
- October 2021 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)
By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)." Harvard Business School Supplement 422-041, October 2021. (Revised January 2022.)